FIELD: medicine.
SUBSTANCE: prevention of developing genital prolapse following hysterectomy is enabled by determining the content of blood C-terminal telopeptides, oxyproline, urine pyrilinx-D. The content of C-terminal telopeptides more than 0.6 ng/ml, oxyproline more than 180 mmole/l, pyrilinx-D more than 8 nmole deoxypyridinoline/mole creatinine requires hysterectomy from a vaginal approach with additional fixation of the uterine ligamentous apparatus.
EFFECT: method provides reducing a risk of developing postoperative genital prolapse.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OPERATIVE CORRECTION OF GENITAL PROLAPSE | 2011 |
|
RU2455955C1 |
| METHOD FOR PREDICTION OF RISK OF GENITAL PROLAPSE IN FEMALES HAVING CHILDBIRTH-RELATED INJURIES IN PAST MEDICAL HISTORY | 2014 |
|
RU2560842C1 |
| METHOD OF CONSERVATIVE TREATMENT OF WOMEN IN PREMENOPAUSE PERIOD WITH PROLAPSE OF GENITALIA | 2009 |
|
RU2427369C1 |
| METHOD FOR SELECTING TACTICS FOR TREATMENT OF GENITAL PROLAPSE IN PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA | 2017 |
|
RU2682497C1 |
| METHOD FOR CORRECTION OF POSTERIOR PELVIC PROLAPSE IN FEMALES | 2014 |
|
RU2559595C1 |
| METHOD OF PREVENTING GENITALIA PROLAPSE IN WOMEN OF REPRODUCTIVE PERIOD | 2009 |
|
RU2427370C1 |
| METHOD OF PREDICTING FORMATION OF POSTHYSTERECTOMIC GENITALS PROLAPSE | 2007 |
|
RU2341181C1 |
| METHOD FOR PREDICTION OF RISK OF GENITAL PROLAPSE IN WOMEN | 2023 |
|
RU2823209C1 |
| METHOD OF LAPAROSCOPIC CORRECTION OF PELVIC ORGAN PROLAPSE IN AN OBESE WOMAN | 2022 |
|
RU2798926C1 |
| METHOD OF TREATING AND PREVENTION OF POSTHYSTERECTOMY PROLAPSE IN EARLIER OPERATED WOMEN | 2010 |
|
RU2446750C2 |
